Aarey Drugs & Pharmaceuticals Promoters Acquire Equity via Warrant Conversion
Aarey Drugs & Pharmaceuticals Ltd 路 Others (Uncategorized) 路 03 Oct 2026, 11:34 pm
Aarey Drugs & Pharmaceuticals Promoters Acquire Equity via Warrant Conversion Aarey Drugs & Pharmaceuticals Limited disclosed an allotment of equity shares to its promoter and promoter group pursuant to warrant conversions as on 30th Sep'26. Total promoter group holding reached 1,32,12,443 equity shares (41.45% of total voting capital and 39.91% on a diluted basis). Key individual post-allotment holdings include Bina Rajesh Ghatalia at 14.13% (45,03,584 shares), Mihir Rajesh Ghatalia at 9.98% (31,80,888 shares), and Nimit Rajesh Ghatalia at 5.18% (16,50,000 shares). Total voting equity expanded to 3,18,74,303 shares post-allotment.
Original exchange filing (PDF)
More announcements from Aarey Drugs & Pharmaceuticals Ltd
- Statement of deviation and variation for the quarter ended September 30, 2026 路 15 Nov 2026
- As per attachment 路 15 Nov 2026
- 1. The Board of Directors of the Company has considered and approved the Standalone Unaudited Financial Results for the second quarter & half year ended on 30th September, 2026 along with .... 路 15 Nov 2026
- Aarey Drugs & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 15 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 14 Nov 2026
- Aarey Drugs and Pharmaceuticals limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 14 Nov 2026
- Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve This is to intimate .... 路 14 Nov 2026
- Revised outcome 路 07 Oct 2026
